Form 4 for SGMT Sagimet Biosciences Inc.
Accepted 2023-12-08 00:00:00 ET · period of report 2023-12-07 · accession 0001104659-23-124678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-08 | 2023-12-07 | SGMT | Happel David | Pres, CEO, Dir | P - Purchase | $4.10 | +1,600 | 627.1K | +0.3% | +$6,560 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2023-12-07 | P | A | 1,600 | $4.10 | 627,100 | D | — | — | (F1) Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.02 per share to $4.16 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price. |